The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 3
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
Cited by
Items 601–700 of 998
Sarmiento-Ortega, V. E., Moroni-González, D., Díaz, A., Morán, C., Brambila, E., & Treviño, S. (2021) · BioMetals · doi:10.1007/s10534-020-00276-8 · Cited by 17
Thiagarajan, P., Bawden, S., & Aithal, G. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040632 · Cited by 19
Sarmiento-Ortega, V. E., Moroni-González, D., Díaz, A., Brambila, E., & Treviño, S. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03471-5 · Cited by 17
Vieira‐Lara, M. A., Reijne, A. C., Koshian, S., Čiapaitė, J., Abegaz, F., Talarovičová, A., van Dijk, T. H., Versloot, C. J., Bandsma, R., Wolters, J. C., et al. (2023) · Diabetes · doi:10.2337/db22-0746 · Cited by 17
Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
Liu, X., Mei, T., Chen, W., & Ye, S. (2017) · Mediators of Inflammation · doi:10.1155/2017/5032708 · Cited by 16
“The pathogenesis of T2DM is caused by damage to pancreatic islet β-cells and insulin resistance [8].”
BackgroundSmith, K., Dennis, K. M. J. H., & Hodson, L. (2025) · Experimental Physiology · doi:10.1113/ep092001 · Cited by 22
“…away fromenergyutilizationandtowardsenergystorage[i.e.,theconversion ofglucosetoglycogenandFAstotriglyceride(TG),andtheattenuation of hepatic glucose production] by affecting post-translational events (e.g., phosphorylation and dephosphorylation) (Hodson & Gunn, 2019; Samuel & Shulman, 2016).”
Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies
Iheagwam, F. N., & Iheagwam, O. T. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100351 · Cited by 32
Janssen, J. A. M. J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189191 · Cited by 20
“DAG and ceramides, both intermediates of fat metabolism when triglycerides are broken down, are the two best-studied putative mediators and leading candidates proposed to be involved in the development of hepatic insulin resistance [126–129].”
González-Casimiro, C. M., Cámara-Torres, P., Merino, B., Diez‐Hermano, S., Postigo, T., Leissring, M. A., Cózar‐Castellano, I., & Perdomo, G. (2021) · Cells · doi:10.3390/cells10092446 · Cited by 15
Modeling type 2 diabetes in rats by administering tacrolimus
Quintana-Pérez, J. C., García‐Dolores, F., Valdez-Guerrero, A. S., Alemán-González-Duhart, D., Arellano-Mendoza, M., Hernández, S. R., Olivares-Corichi, I. M., García-Sánchez, J. R., Ferrara, J. T., & Cach, F. T. (2022) · Islets · doi:10.1080/19382014.2022.2051991 · Cited by 15
“The first mechanism affected is a completely insulin-dependent pathway of glucose transport mediated by glucose transporter 4 (GLUT4), followed by insulininduced phosphorylation of the tyrosine residues in insulin receptors 1, and finally the recruitment of the substrates necessary for glucose deposition in skeletal m…”
BackgroundZhao, M., Zhang, X.-G., Tang, Y.-P., Zhu, Y.-X., Nie, H.-Y., Bu, D., Fang, L., & Li, C. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105617 · Cited by 16
Flori, L., Piragine, E., Calderone, V., & Testai, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122491 · Cited by 16
Gupte, M., Umbarkar, P., Singh, A. P., Zhang, Q., Tousif, S., & Lal, H. (2020) · Cells · doi:10.3390/cells9051120 · Cited by 17
Rodríguez‐Calvo, R., Samino, S., Girona, J., Martínez-Micaelo, N., Ràfols, P., García‐Altares, M., Guaita‐Esteruelas, S., Junza, A., Heras, M., Yanes, Ó., et al. (2020) · Biomolecules · doi:10.3390/biom10091275 · Cited by 16
“All these processes promote liver triglyceride accumulation [8,9].”
BackgroundVázquez-Jiménez, J. G., Corpus-Navarro, M. S., Rodriguez-Chavez, J. M., Ramírez, H. J. J., Hernández-Aranda, J., Galindo‐Hernández, O., Machado-Contreras, J. R., Trejo-Trejo, M., Guerrero-Hernández, A., & Olivares-Reyes, J. A. (2021) · Metabolites · doi:10.3390/metabo11020091 · Cited by 16
“However, together with insulin resistance, there is often a β -cell reduction, resulting in sustained hyperglycemia and type 2 diabetes mellitus (T2DM) [2,3].”
Akhtar, S., Culver, S. A., & Siragy, H. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-90952-7 · Cited by 17
Mthembu, S. X. H., Dludla, P. V., Nyambuya, T. M., Kappo, A. P., Madoroba, E., Ziqubu, K., Nyawo, T. A., Nkambule, B. B., Silvestri, S., Muller, C. J. F., et al. (2021) · Biochimie · doi:10.1016/j.biochi.2021.09.010 · Cited by 19
Investigation of FcRn‐Mediated Transepithelial Mechanisms for Oral Nanoparticle Delivery Systems
Yu, Y., Wu, Z., Wu, J., Shen, X., Wu, R., Zhou, M., Li, L., & Huang, Y. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100145 · Cited by 15
Pescari, D., Mihuţa, M. S., Bena, A., & Stoian, D. (2025) · Nutrients · doi:10.3390/nu17050798 · Cited by 15
“Elevated resistin levels are strongly linked to insulin resistance, as they impair insulin signaling, increase hepatic glucose production, and reduce peripheral glucose uptake, contributing to hyperglycemia and metabolic syndrome [44].”
da Costa, J. S. D., Silocchi, C., Schwendler, S. C., Morimoto, T., Mottin, V. H. M., Paniz, V. M. V., de Bairros, F. S., & Olinto, M. T. A. (2020) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-4974000300025 · Cited by 36
D’Angelo, S., Ferrara, L., & Joksimović, M. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401318666220317140717 · Cited by 15
G6PD Deficiency Is Crucial for Insulin Signaling Activation in Skeletal Muscle
Jiang, A., Guo, H., Jiang, X., Tao, J., Wu, W., & Liu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137425 · Cited by 13
Nasrollahi, Z., Shahanipour, K., Monajemi, R., & Ahadi, A. M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14506 · Cited by 20
Nagarajan, S. R., Livingstone, E. J., Monfeuga, T., Lewis, L. C., Ali, S. H. L., Chandran, A., Dearlove, D., Neville, M. J., Chen, L., Maroteau, C., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155563 · Cited by 15
“Interestingly, we observed greater pAKT levels in the higher glucose-producing si MLX -treated hepatocytes, highlighting the relative importance of insulin signalling vs substrate availability in controlling hepatic glucose production [50].”
BackgroundImmunological Imbalances Associated with Epileptic Seizures in Type 2 Diabetes Mellitus
Phoswa, W. N., & Mokgalaboni, K. (2023) · Brain Sciences · doi:10.3390/brainsci13050732 · Cited by 17
“Insulin resistance contributes to the pathogenesis of DM, more particularly T2DM [69].”
BackgroundInsulin resistance in NSCLC: unraveling the link between development, diagnosis, and treatment
Zhan, S., Wang, L., Wang, W., & Li, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1328960 · Cited by 16
Msane, S., Khathi, A., & Sosibo, A. M. (2024) · Nutrients · doi:10.3390/nu16162692 · Cited by 22
“Insulin resistance (IR) occurs when the main target tissues for insulin action in glucose metabolism do not respond to insulin as they should due to chronic energy surpluses [39].”
BackgroundFan, X., Li, B., Zhang, F., Liu, M., Kwan, H. Y., Liu, Z., & Su, T. (2024) · Advanced Science · doi:10.1002/advs.202413525 · Cited by 14
Chen, X., Wu, W., Wang, L., Shi, Y., Shen, F., Gu, X., & Jia, Z. (2017) · Medical Science Monitor · doi:10.12659/msm.904755 · Cited by 15
“Many studies demonstrated that adipose inflammation plays an important part in insulin resistance [37].”
BackgroundCentral and peripheral effects of physical exercise without weight reduction in obese and lean mice
de Carvalho, F. P., Moretto, T. L., Benfato, I. D., Barthichoto, M., Ferreira, S. M., Costa-Júnior, J. M., & de Oliveira, C. A. M. (2018) · Bioscience Reports · doi:10.1042/bsr20171033 · Cited by 15
Sevoflurane Impairs Insulin Secretion and Tissue‐Specific Glucose Uptake In Vivo
Høyer, K. F., Nielsen, T. S., Risis, S., Treebak, J. T., & Jessen, N. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13087 · Cited by 14
Prudêncio, C. B., Rudge, M. V. C., Pinheiro, F. A., Filho, C. I. S., Nunes, S. K., Pedroni, C. R., Junginger, B., & Barbosa, A. M. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223261 · Cited by 16
Mann, J. P., Carter, P. R., Armstrong, M. J., Abdelaziz, H. K., Uppal, H., Patel, B., CHANDRAN, S. R., More, R. S., Newsome, P. N., & Potluri, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241357 · Cited by 14
Rifampicin impairs adipogenesis by suppressing NRF2-ARE activity in mice fed a high-fat diet
Gao, T., Lai, M., Zhu, X., Ren, S., Yin, Y., Wang, Z., Liu, Z., Zuo, Z., Hou, Y., Pi, J., et al. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115393 · Cited by 16
Natsume, Y., Yamada, T., Iida, T., Ozaki, N., Gou, Y., Oshida, Y., & Koike, T. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08013 · Cited by 16
“Insulin resistance is a condition in which insulin cannot exert its effect in insulin-sensitive target tissues, including skeletal muscles, adipose tissues, and the liver [1].”
BackgroundYao, Z., Song, S., Li, X., Wang, W., Ren, P., Wang, H., Xie, Y., & Li, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105063 · Cited by 14
Triglyceride–Glucose Index May Predict Renal Survival in Patients with IgA Nephropathy
Qin, A., Tan, J., Wang, S., Dong, L., Jiang, Z., Yang, D., Zhou, H., Zhou, X., Tang, Y., & Qin, W. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175176 · Cited by 16
“IR can induce glucose metabolism imbalance, causing excessive glycosylation, which can promote smooth muscle cell proliferation, collagen crosslinking, and collagen deposition, as well as triggering inflammation and oxidative stress [25].”
BackgroundLipid and inflammatory biomarker profiles in early insulin resistance
Marcelino-Rodríguez, I., García, J. O., Sánchez, J. J. A., González, D. A., Coello, S. D., Díaz, B. B., Gannar, F., Pérez, M. D. C. R., Elosúa, R., & de León, A. C. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0885-6 · Cited by 16
MG53 and disordered metabolism in striated muscle
Hu, X., & Xiao, R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.013 · Cited by 15
Fc Gamma Receptor IIb Expressed in Hepatocytes Promotes Lipid Accumulation and Gluconeogenesis
Shu, T., Song, X., Cui, X., Ge, W., Gao, R., & Wang, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102932 · Cited by 14
“G6Pase and PEPCK are important enzymes for gluconeogenesis, which restrain hyperglycemia [3,4].”
BackgroundCheng, F., Yuan, G., He, J., Shao, Y., Zhang, J., & Guo, X. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s229838 · Cited by 15
“an elevated risk of developing Type 2 diabetes mellitus (T2DM), cardiovascular disease, and hypertension.(2) During obesity, the production of inflammatory cyto-”
BackgroundGao, P., Hu, Y., Wang, J., Ni, Y., Zhu, Z., Wang, H., Yang, J., Huang, L., & Fang, L. (2020) · Medical Science Monitor · doi:10.12659/msm.924334 · Cited by 17
“Insulin resistance is a pathological condition with impaired sensitivity to insulin in target tissues including liver, heart, muscle, and adipose tissue [1].”
BackgroundLü, X., Hu, S., Liao, Y., Zheng, J., Zeng, T., Zhong, X., Liu, G., Gou, L., & Chen, L. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00090.2020 · Cited by 14
López-Pérez, D., Redruello-Romero, A., García-Rubio, J., Arana, C., García-Escudero, L. Á., Tamayo, F., Puentes-Pardo, J. D., Moreno-SanJuan, S., Salmerón, J., Blanco, A. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664576 · Cited by 19
“Also, it boosts gluconeogenesis in the liver, prompting hyperglycemia (61) and causing hepatic steatosis (8).”
BackgroundPathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 16
Exploring obesity phenotypes: a longitudinal perspective
Rosero, R., Tamayo, M., Correa, R. R., Pantalone, K. M., Creel, D. B., Burguera, B. G., & Griebeler, M. L. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09976-3 · Cited by 17
Kim, M., Lee, S., Hur, J., & Shin, D. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01189-3 · Cited by 13
“Insulin resistance further contributes to elevated blood hexose levels by impairing glucose transport to tissues [77].”
Varghese, J., Varghese, J., John, N. M., Deschemin, J., Vaulont, S., McKie, A. T., & Jacob, M. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109175 · Cited by 16
Metz, M., O’Hare, J., Cheng, B., Puchowicz, M., Buettner, C., & Scherer, T. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101723 · Cited by 14
“Furthermore, ectopic lipid storage in the liver and the skeletal muscle due to unrestrained lipolysis impairs intracellular insulin signaling [6].”
BackgroundMoon, D. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08746-1 · Cited by 17
“and exert significant pressure on healthcare systems [3, 4].”
BackgroundGupta, R. S., Grover, A. S., Kumar, P., Goel, A., Banik, S. P., Chakraborty, S., Rungta, M., Bagchi, M., Pal, P., & Bagchi, D. (2024) · Food & Nutrition Research · doi:10.29219/fnr.v68.10667 · Cited by 20
“Adiponectin is a cytokine secreted by adipose tissues that contributes to the regulation of glucose homeostasis by dampening gluconeogenesis and increasing glycolysis and β -oxidation (7–9).”
Some paradoxes and unresolved aspects of hepatic de novo lipogenesis
Jones, J. G. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00020-7 · Cited by 16
“Given that there is a substantial in fl ow of fatty acids into the liver from adiposetissuelipolysisinfastingaswellasfedstates 17,18 ,thisactionislikelyto be a signi fi cant contributor to elevated hepatic triglyceride levels.”
The influence of metabolic disorders on adaptive immunity
Collins, T. J. C., Morgan, P. K., Man, K., Lancaster, G. I., & Murphy, A. J. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01206-1 · Cited by 17
“Research into metabolic disorders has primarily focussed on metabolic tissues, such as the liver, adipose tissue, and skeletal muscle [78].”
Ziziphus jujuba (Jujube) in Metabolic Syndrome: From Traditional Medicine to Scientific Validation
Rahbardar, M. G., Kakhki, H. F., & Hosseinzadeh, H. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00581-5 · Cited by 21
“The lipid accumulation impairs glucose uptake and insulin signaling, resulting in further insulin resistance [37].”
Uchiyama, A., Kon, K., Morinaga, M., Fukada, H., Yaginuma, R., Fukuhara, K., Yamashina, S., Iwabuchi, K., & Ikejima, K. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151242 · Cited by 16
Gul, P., Khan, J., Li, Q., & Liu, K. (2025) · Food Research International · doi:10.1016/j.foodres.2025.115671 · Cited by 26
Ahmed, S. M. I., Adnan, H., Khawaja, M. A., & Butler, A. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020753 · Cited by 17
“Insulin resistance is characteristic of T2DM and is seen in response to abnormalities in the signaling pathway due to the dysregulation of key proteins [76,77].”
Li, Y., Zhong, Y., Cheng, Q., Wang, Y., Fan, Y., Yang, C., Ma, Z., Li, Y., & Li, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00717 · Cited by 15
Corral‐Jara, K. F., Cantini, L., Poupin, N., Ye, T., Rigaudière, J., Vincent, S. D. S., Pinel, A., Morio, B., & Capel, F. (2020) · Nutrients · doi:10.3390/nu12123864 · Cited by 16
“Inhibition of insulin signaling may arise from the deposition of FA or other lipid mediators in the peripheral tissues, proteins secreted by dysfunctional/inflamed adipose tissue through intracellular mechanism which remain partially characterized [3].”
BackgroundWisessaowapak, C., Watcharasit, P., & Satayavivad, J. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.06.002 · Cited by 13
Yang, X., Wang, W., Huang, Y., Yue, S., Zhang, B.-Y., Gao, H., Zhang, L., Yan, D., & Tang, Y. (2021) · ACS Omega · doi:10.1021/acsomega.1c01209 · Cited by 14
Campos-Almazán, M. I., Flores-Ramos, M., Hernández‐Campos, A., Castillo, R., Sierra‐Campos, E., Torgeson, K. R., Peti, W., Valdez-Solana, M. A., Oria‐Hernández, J., Méndez, S. T., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116418 · Cited by 13
Perspectives on diacylglycerol-induced improvement of insulin sensitivity in type 2 diabetes
Li, D., Zhu, Y., Wang, Y., Zou, Q., Duan, J., Sun‐Waterhouse, D., & Sun, B. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.11.004 · Cited by 14
Barbieri, E., Santoro, N., & Umano, G. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1062341 · Cited by 14
Novel therapies in type 2 diabetes: insulin resistance
Tahrani, A. A. (2017) · Practical Diabetes · doi:10.1002/pdi.2109 · Cited by 18
Spradley, F. T., Smith, J. A., Alexander, B. T., & Anderson, C. D. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00394.2017 · Cited by 14
“Increased inflammation in adipose tissue is thought to maintain ectopic lipid accumulation in NAFLD and propagation of hepatic insulin resistance and T2DM (101, 180).”
BackgroundGuzmán‐Flores, J. M., Flores-Pérez, E. C., Hernández‐Ortíz, M., Vargas‐Ortiz, K., Ramírez-Emiliano, J., Encarnación‐Guevara, S., & Pérez‐Vázquez, V. (2018) · Biomolecules · doi:10.3390/biom8020035 · Cited by 14
Phielix, E., Begovatz, P., Gancheva, S., Bierwagen, A., Moonen‐Kornips, E., Schaart, G., Hesselink, M. K. C., Schrauwen, P., & Roden, M. (2019) · JCI Insight · doi:10.1172/jci.insight.127928 · Cited by 17
“The insulin-mediated translocation of GLUT4 to the sarcolemmal membrane is impaired in patients with T2DM (17, 18) and results in lower intramuscular glucose and in turn lower G6P concentrations (19).”
BackgroundInfluentialHerrera-Ojeda, J. L., Blanco-Palma, R. S., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02621-5 · Cited by 16
“[ 22].”
Liu, D., Zhao, L., Wang, Y., Wang, L., Wu, D., & Liu, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18121890 · Cited by 25
“The insulin signaling pathway serves as a critical intracellular cascade for regulating glucose and lipid metabolism [81,82].”
Huang, S., Xie, W., Ye, Y., Liu, J., Qu, H., Shen, Y., Xu, T., Zhao, Z.-H., Shi, Y., Shen, J., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00985-5 · Cited by 14
“Insulin activates phosphoinositide 3-kinase (PI3K)/Akt signaling cascade and subsequently stimulates the phosphorylation and inactivation of GSK3β [6, 7], leads to the activation of glycogen synthase (GS) [8, 9], and ultimately triggers glycogen synthesis [10].”
BackgroundEmerging role of N6-methyladenosine in the homeostasis of glucose metabolism
Sun, Y., Zhao, T., Li, L., Wang, Z., & Li, H. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2023 · Cited by 15
Mthembu, S. X. H., Mazibuko-Mbeje, S. E., Ziqubu, K., Muvhulawa, N., Marcheggiani, F., Cirilli, I., Nkambule, B. B., Muller, C. J. F., Basson, A. K., Tiano, L., et al. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02890-0 · Cited by 13
“With accumulative evidence highlighting the significant role of high-fat diet (HFD) feeding in driving the initiation and progression of both insulin resistance and mitochondrial dysfunction [45, 49, 70].”
BackgroundZhan, Y., Lou, H., Shou, R., Li, A., Shang, J., Jin, Y., Lü, L., Zhu, L., Lu, X., & Fan, X. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133233 · Cited by 12
Yang, L., Jiang, Z., Yang, L., Zheng, W., Chen, Y., Qu, F., Crabbe, M. J. C., Zhang, Y., Andersen, M. E., Zheng, Y., et al. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.3c11009 · Cited by 13
Qian, X., Wu, W., Chen, B., Zhang, S., Xiao, C., Chen, L., Chen, J., Ke, L., He, M., & Li, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1425024 · Cited by 12
Samji, N. S., Verma, R., Keri, K., Singal, A. K., Ahmed, A., Rinella, M. E., Bernstein, D., Abdelmalek, M. F., & Satapathy, S. K. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05716-1 · Cited by 12
Murphy, A. M., Smith, C. E., Murphy, L. M., Follis, J. L., Tanaka, T., Richardson, K., Noordam, R., Lemaître, R. N., Kähönen, M. A. P., Dupuis, J., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900226 · Cited by 11
Xiang, Y., Liu, Y., Xiao, F., Sun, X., Wang, X., & Wang, Y. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.099 · Cited by 12
Mokwena, M. A. M., Engwa, G. A., Nkeh-Chungag, B. N., & Sewani-Rusike, C. R. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03459-z · Cited by 12
“IR is a metabolic state characterised by hyperinsulinaemia and hyperglycaemia in which cells fail to sufficiently respond to insulin action [19].”
BackgroundSilva, T. O., Norde, M. M., Vasques, A. C. J., Zambon, M. P., Antônio, M. Â. R. D. G. M., Rodrigues, A. M. D. B., BRAMS group, Geloneze, B., & Brazilian Metabolic Syndrome Study investigators (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191935 · Cited by 17
Xie, E., Ye, Z., Wu, Y., Zhao, X., Li, Y., Shen, N., Guo, X., Gao, Y., & Zheng, J. (2023) · European journal of medical research · doi:10.1186/s40001-023-01410-1 · Cited by 13
Moradi, N., Fadaei, R., Rashidbeygi, E., Kargasheh, F. B., Malek, M., Nahrkhalaji, A. S., & Fallah, S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1742164 · Cited by 12
“Conversely, insulin resistance is the pathogenic mechanism for developing and progression of T2DM (Samuel and Shulman 2016).”
BackgroundHamano, M., Esaki, K., Moriyasu, K., Yasuda, T., Mohri, S., Tashiro, K., Hirabayashi, Y., & Furuya, S. (2021) · Nutrients · doi:10.3390/nu13103468 · Cited by 13
“Clinical and experimental studies have shown that hepatic insulin resistance is strongly associated with non-alcoholic fatty liver disease (NAFLD) [31,32].”
BackgroundLow Carbohydrate Diets for Diabetic Cardiomyopathy: A Hypothesis
Kleissl-Muir, S., Rasmussen, B., Owen, A. J., Zinn, C., & Driscoll, A. L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.865489 · Cited by 192
“Even in the absence of overnutrition, CHO are the major drivers of dyslipidaemia (69, 70).”
BackgroundPathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., John‐Kalarickal, J., & Fonseca, V. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_13 · Cited by 15
van Stijn, M. F. M., Soeters, M. R., van Leeuwen, P. A. M., Schreurs, W. H. P., Schoorl, M. G., Twisk, J. W. R., Bandt, J. P. D., Bonnefont‐Rousselot, D., Cynober, L., Ackermans, M. T., et al. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607117711691 · Cited by 12
Yan, C., Burley, G., Gao, H., & Shi, Y. (2025) · Endocrinology · doi:10.1210/endocr/bqaf118 · Cited by 12
Liu, J., Kang, J., Liang, P., Song, Z., Li, G., Jin, X., & Wu, H. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02826-1 · Cited by 14
“RCS restricted cubic spline; TyG, triglyceride glucose index the degradation of endothelial glycocalyx, thereby exacerbating the destabilization of atherosclerotic plaques [63].”
Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion
Bethea, M. M., Bozadjieva-Kramer, N., & Sandoval, D. A. (2021) · Endocrinology · doi:10.1210/endocr/bqab150 · Cited by 12
Zhao, H., Wang, Y., Wang, C., & Meng, Q.-K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1323615 · Cited by 11
Feng, Y., Lin, H., Tan, H., & Liu, X. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.03.004 · Cited by 11
Huneault, H. E., Chen, C., Cohen, C. C., Liu, X., Jarrell, Z. R., He, Z., DeSantos, K., Welsh, J. A., Maner-Smith, K. M., Ortlund, E. A., et al. (2024) · Metabolites · doi:10.3390/metabo14040191 · Cited by 11
“In muscle tissue, DG species have been shown to impair insulin signaling, leading to insulin resistance [101].”
BackgroundLiu, B., Ren, X., & Tian, W. (2024) · Nutrition · doi:10.1016/j.nut.2024.112469 · Cited by 11
Cilostazol Attenuates Hepatic Steatosis and Intestinal Disorders in Nonalcoholic Fatty Liver Disease
Min, T., Qiu, S., Bai, Y., Cao, H., Guo, J., & Su, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116280 · Cited by 12
“An imbalance between liver lipid storage and lipid clearance, such as increased de novo lipogenesis and fatty acid content, can lead to liver cell damage and lead to peripheral insulin resistance, further promoting lipid production, with glucose and fatty acids as the substrates [10].”
BackgroundFu, X., Zhao, Y., Wu, Y., Wen, L., Huo, W., Zhang, D., Zhang, Y., Li, J., Lu, X., Hu, F., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16074 · Cited by 19
Luo, Y., Liu, L., Liu, M., Tang, C., Liu, H., Wang, M., Feng, G., Wu, J., & Wu, W. (2024) · Clinical Endocrinology · doi:10.1111/cen.15171 · Cited by 13
“On the other side, the increase in TG levels induces an increase in free fatty acid levels, resulting from the increase in the flux of free fatty acid from adipose tissue to non ‐ adipose tissue, which also promotes IR [24].”
Shi, J., Chen, J., Cheng, C., Li, W., Li, M., Ye, S., Liu, Z., & Ding, Y. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128365423250126035306 · Cited by 14
Sevilla-González, M. D. R., Smith, K., Wang, N., Jensen, A. E., LITKOWSKI, E. M., Kim, H., DICORPO, D. A., Hsu, S. C., Cui, J., Liu, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57452-y · Cited by 18
“For example, while the HIR cluster associates with lower MI (which could fit to findings from mendelian randomization analyses about hepatic fat and CV outcomes), it is associated with lower eGFR, suggesting that this mechanism could underly diabetic nephropathy to some extent.”
Duan, H., Zhang, Q., Liu, J., Li, R., Peng, W., & Wu, C. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291638 · Cited by 11
“Insulin, a peptide hormone released by pancreatic beta cells, is part of a family of peptides which includes insulin-like growth factors (IGF) I and II.26 It has the ability to regulate the blood glucose levels, which is of great significance to maintain the glucose balance in vivo.27 It has been reported that the abn…”
Background
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.